HERA Biotech is developing and commercializing a non-surgical diagnostic test for definitive diagnosis and staging of endometriosis.

HERA Biotech

Our Vision: To be the world leader in understanding & addressing diagnostic & therapeutic deficiencies in women's health. 
Our Mission: Driven to advance the standard of care in women's health 
Our First Order of Business: Validate and commercialize the first non-surgical method of diagnosing, and staging, endometriosis.

Althea Ventures

Kendra Scott Women's Entrepreneurial Leadership Institute

Stella Angels

Coyote Ventures

Hera Biotech

Hey, hey, hey!!! So proud that our company was selected from >1000 applicants as one of the 10 to participate in this, Class 10! Here we goooo!

So proud to see our CEO Somer Baburek, MBA, and our team at Hera being recognized for our work in #womenshealth!

At Hera, we are incredibly passionate about improving definitive diagnostics for endometriosis, taking it from surgical to simple, but always recognizing the importance of a tissue-based connection with a tissue-based disease. We also see the importance of elucidating the whole burden of endometriosis. It's easy to minimize the impact of something that is not directly affecting you or a loved one. We believe that endometriosis harms the whole of society, not just those that it immediately impacts, and we have dedicated precious resources to the research needed to prove this. 

We are so very pleased to present our 4th white paper in this series. We cannot thank Mark Gannott, A/Prof Mike Armour, Ryan Castle, Diana Nancy Contreras, MD MPH, Ally Schott, and Emma Ricci-De Lucca, the team that worked to get this paper done. This one was a heavy lift and they delivered something so data-driven, yet so easy to digest. Thank you to each of you, we are so appreciative of your dedication.

Please view the visual executive summary below and read the new Hera white paper here: https://lnkd.in/gwt8RzuC

#endometriosis #womenshealth #biotech #surgicaltosimple #socialdeterminantsofhealth

Experience, expertise, and innovation: Hera's team brings a wealth of knowledge in medical diagnostics development, approval, and more. MetriDx™, the groundbreaking diagnostic test for endometriosis, will expand access for OB/GYNs and fertility clinics. At Hera Biotech, our commitment lies in enhancing our understanding of endometriosis and creating an accessible diagnostic test for women grappling with this condition.

#FromSurgicalToSimple

Talking about endometriosis can be as tricky as explaining a color you've never seen. It's intimate, it's personal, and it's often met with misunderstanding. We know it can be difficult, but it doesn't have to be! Here are a few ways you can openly explain endometriosis to someone.
#FromSurgicalToSimple

Did you know there are incredible support groups like Endometriosis Association, EndoFound, SpeakEndo, and many more? Connect with others who understand your journey, share experiences, and access invaluable resources. You're not alone. 💛
#EndometriosisSupport #FromSurgicalToSimple

Linode

Akamai Hosted

Co-Founder

Nameer Kirma

Co-Founder, Executive Chairman

Paul Castella

Business Management

Somer Baburek, MBA

Somer Baburek

Pharmaceutical Companies (Top 10K)

Texas Companies With Fewer Than 100 Employees (Top 10K)

Pharmaceutical Seed Stage Companies With Fewer Than 100 Employees

Cornell University Alumni Founded Companies

Hera Biotech is a biotechnology company that is mainly developed for women's health and reproductive medicines. The company was founded in 2020 and is headquartered in San Antonio, Texas, United States.

Cedars-Sinai Accelerator

Seed Round - Hera Biotech

San Antonio

Texas

United States

North America

Announcing the 2024 Women's Leadership Award winners

Hera Biotech Announces Positive Interim Results From Endometriosis Diagnostic Study

Newzchain on LinkedIn: #biotech #healthcareinnovation #endometriosis #womenshealth…

Hera snaps up Scailyte endometriosis assets

Hera Biotech to Acquire Endometriosis Diagnostic Assets from Scailyte in Move Towards Non-Surgical Diagnosis

Hera Biotech acquires endometriosis diagnostic assets from Scailyte

Focusing on Women's Health

Ignite Healthcare Network picks EndoMedix, Hera Biotech ...

A non-surgical diagnostic test for early and definitive diagnosis and staging of endometriosis using micro-fluidic analysis of single cells from a uterine brush biopsy.

Kenya

Africa

Canada

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 31, 2024 10:57 AM	bc066bf1
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	ef07d6a2
crunchbase profile	general	Nov 22, 2024 3:42 PM	60efc34a
li profile	general	Aug 31, 2024 10:57 AM	e5381df9
translate crunchbase fundingrounds	general	Nov 22, 2024 8:38 PM	415e5ed5
peers	general	Aug 31, 2024 10:57 AM	ec58c742
news basic	general	Aug 31, 2024 10:57 AM	e768eab7
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:HERABIOTECH

HERA Biotech